Seth Klarman
Baupost Group
Baupost Group Portfolio 13F
Seth Klarman Holdings Activity
- Portfolio value:
- $6.77B≈ (-$3B≈)
- Previous value:
- $9.30B≈
- # of changes:
- 35
- New positions:
- 3
- Reported for:
- 30 Jun 2022 (Q2)
- Latest filing date:
- 12 Aug 2022
Baupost Group has disclosed a total of 35 changes to the portfolio in the (2022 Q2) SEC report(s): increased the number of shares of 4, bought 3 totally new, decreased the number of shares of 22 and completely sold out 6 position(s).
What stocks did Seth Klarman buy in 2022 Q2?
During 2022 Q2 Seth Klarman has bought 7 securities out of which top 5 purchases (by % change to portfolio) were (QRVO) Qorvo Inc (added shares +4.84%), (LSXMK) Liberty Media Corp Series C Liberty SiriusXM (added shares +18.67%), (LSXMA) Liberty Media Corp Series A Liberty SiriusXM (added shares +30.34%), (WBD) Warner Bros Discovery Inc (new buy) and (EDU) New Oriental Education & Technology (new buy).
35 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Amazon.com Inc
|
new
|
+598,000
|
598,000
|
+0.94%
|
$106.21
|
+168.60%($285.28)
|
0.94%
|
2022 Q2
|
≈ 0.25 years
|
|
|
|
New Oriental Education & Technology
|
new
|
+8,000,000
|
8,000,000
|
+2.41%
|
$20.36
|
+191.11%($59.27)
|
2.41%
|
2022 Q2
|
≈ 0.25 years
|
|
|
|
Warner Bros Discovery Inc
|
new
|
+18,000,000
|
18,000,000
|
+3.57%
|
$13.42
|
+96.09%($26.32)
|
3.57%
|
2022 Q2
|
≈ 0.25 years
|
|
|
|
Gray Television Inc
|
+75.07%
|
+969,084
|
2,260,000
|
+0.24%
|
$16.89
|
-75.22%($4.18)
|
0.56%
|
2022 Q1
|
≈ 0.50 years
|
|
|
|
Liberty Media Corp Series A Liberty SiriusXM
|
+30.34%
|
+1,704,918
|
7,324,854
|
+0.91%
|
$36.04
|
|
3.90%
|
2020 Q3
|
≈ 2.00 years
|
|
|
|
Liberty Media Corp Series C Liberty SiriusXM
|
+18.67%
|
+2,084,053
|
13,245,642
|
+1.11%
|
$36.05
|
|
7.06%
|
2020 Q1
|
≈ 2.50 years
|
|
|
|
Qorvo Inc
|
+4.84%
|
+321,324
|
6,967,036
|
+0.45%
|
$94.32
|
-5.28%($89.34)
|
9.71%
|
2017 Q1
|
≈ 5.50 years
|
|
|
|
Nuvation Bio Inc
|
-0.24%
|
-25,300
|
10,418,194
|
-0%
|
$3.24
|
+93.98%($6.28)
|
0.50%
|
2021 Q1
|
≈ 1.50 years
|
|
|
|
REINVENT TECHNOLOGY A -CW25
|
-0.75%
|
-6,477
|
861,419
|
-0%
|
$1.09
|
|
0.01%
|
2021 Q1
|
≈ 1.50 years
|
|
|
|
THERAVANCE BIOPHARMA INC
|
-1.64%
|
-224,107
|
13,419,226
|
-0.02%
|
$9.06
|
+86.15%($16.86)
|
1.80%
|
2014 Q2
|
≈ 8.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.